SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 134 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $30,036,000 | -10.6% | 532,164 | -1.9% | 0.04% | -2.4% |
| Q4 2021 | $33,612,000 | -4.9% | 542,316 | -2.6% | 0.04% | -4.7% |
| Q3 2021 | $35,333,000 | -24.2% | 556,940 | -1.5% | 0.04% | -23.2% |
| Q2 2021 | $46,609,000 | +9.8% | 565,578 | -2.0% | 0.06% | +1.8% |
| Q1 2021 | $42,452,000 | +1.1% | 577,032 | -0.3% | 0.06% | -1.8% |
| Q4 2020 | $41,993,000 | +51.3% | 579,044 | -0.6% | 0.06% | +40.0% |
| Q3 2020 | $27,758,000 | +54.2% | 582,287 | +35.8% | 0.04% | +37.9% |
| Q2 2020 | $18,003,000 | – | 428,644 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |